WASHINGTON — A sudden medical incident interrupted President Trump’s Oval Office announcement on new weight-loss drug pricing earlier today. An unidentified individual collapsed during the event, and Dr. Mehmet Oz was seen attending to the person.
Join our WhatsApp groupSubscribe to our Daily Roundup Email
Social media reports are identifying the individual as Gordon Findlay, executive vice president and head of Novo Nordisk’s U.S. operations, with users sending prayers for his well-being. The circumstances of the collapse remain unclear, and it has not been confirmed whether the individual is in critical condition.
President Trump appeared visibly shaken as the situation unfolded. White House staff quickly ushered the press out of the room, halting live coverage of the event.
The announcement had been intended to highlight Trump’s plan to reduce the cost of popular weight-loss medications, including changes in Medicare and Medicaid coverage. No official statements have been released regarding the individual’s condition, and updates are expected as more information becomes available.
..Too much of his booster juice?